120
Participants
Start Date
April 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
T-DEN F17
A single dose of 0.5 mL of the dengue vaccine was injected subcutaneously into the upper-outer triceps/deltoid area of the non-dominant arm at Day 0 and at 6 months.
T-DEN F-19
A single dose of 0.5 mL of the dengue vaccine was injected subcutaneously into the upper-outer triceps/deltoid area of the non-dominant arm at Day 0 and at 6 months.
Placebo Comparator
A single dose of 0.5 mL of the placebo sterile solution of buffer identical in appearance to vaccine)was injected subcutaneously into the upper-outer triceps/deltoid area of the non-dominant arm at Day 0 and at 6 months.
Phramongkutklao Hospital, Bangkok
Collaborators (1)
GlaxoSmithKline
INDUSTRY
U.S. Army Medical Research and Development Command
FED